Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedAir Labs is a private Ohio-based healthcare and life sciences company focused on pandemic-response products, diagnostics, and virus-mitigation technologies. The company markets SERENIO powered by SHYCOCAN, a device intended to neutralize airborne and surface coronaviruses in enclosed spaces, and has promoted a multi-virus rapid antigen testing kit designed to detect COVID-19 and influenza from a single swab. MedAir Labs positions itself as a human-centered innovation company working with global manufacturing and commercialization partners. Its activities appear concentrated in diagnostics, infection-control devices, and related healthcare products rather than traditional therapeutics. Publicly available information suggests it remains a small, privately held operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedAir Labs.